Education
About Us
Working with TipRanks
Follow Us
CervoMed (CRVO)
NASDAQ:CRVO
Total Valuation
CervoMed has a market cap or net worth of $85.72M. The enterprise value is $44.39M.
Market Cap$85.72M
Enterprise Value$44.39M
Share Statistics
CervoMed has 8,702,719 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,702,719
Owned by Insiders45.83%
Owned by Institutions0.21%
Financial Efficiency
CervoMed’s return on equity (ROE) is -0.42 and return on invested capital (ROIC) is -46.50%.
Return on Equity (ROE)-0.42
Return on Assets (ROA)-0.38
Return on Invested Capital (ROIC)-46.50%
Return on Capital Employed (ROCE)-0.46
Revenue Per Employee649.20K
Profits Per Employee-1.09M
Employee Count15
Asset Turnover0.23
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CervoMed is ―. CervoMed’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.48
Price to FCF0.00
Price to Operating Cash Flow-3.39
PEG Ratio―
Income Statement
In the last 12 months, CervoMed had revenue of 9.74M and earned -16.29M in profits. Earnings per share was -2.02.
Revenue9.74M
Gross Profit-9.06M
Operating Income-18.23M
Pretax Income-16.29M
Net Income-16.29M
EBITDA-18.23M
Earnings Per Share (EPS)-2.02
Cash Flow
In the last 12 months, operating cash flow was -4.85M and capital expenditures -13.64K, giving a free cash flow of -4.91M billion.
Operating Cash Flow-4.85M
Free Cash Flow-4.91M
Free Cash Flow per Share-0.56
Dividends & Yields
CervoMed pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.20
52-Week Price Change-18.80%
50-Day Moving Average7.58
200-Day Moving Average7.04
Relative Strength Index (RSI)65.46
Average Volume (3m)619.67K
Important Dates
CervoMed upcoming earnings date is Aug 18, 2025, Before Open (Confirmed).
Last Earnings DateMay 14, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
CervoMed as a current ratio of 11.11, with Debt / Equity ratio of 0.00%
Current Ratio11.11
Quick Ratio11.11
Debt to Market Cap0.00
Net Debt to EBITDA0.49
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CervoMed has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CervoMed EV to EBITDA ratio is -0.54, with an EV/FCF ratio of -0.60.
EV to Sales1.02
EV to EBITDA-0.54
EV to Free Cash Flow-0.60
EV to Operating Cash Flow-0.60
Balance Sheet
CervoMed has $35.24M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$35.24M billion.
Cash & Marketable Securities$35.24M
Total Debt$0.00
Net Cash-$35.24M
Net Cash Per Share-$4.05
Tangible Book Value Per Share$4.86
Margins
Gross margin is 100.00%, with operating margin of -187.18%, and net profit margin of -167.29%.
Gross Margin100.00%
Operating Margin-187.18%
Pretax Margin-167.29%
Net Profit Margin-167.29%
EBITDA Margin-187.18%
EBIT Margin-167.29%
Analyst Forecast
The average price target for CervoMed is $20.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$20.50
Price Target Upside108.12% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast142.42%
EPS Growth Forecast53.38%